By Allen C. Ho, MD, and Robert L. Avery, MD
Clinical trials demonstrate that both epiretinal and subretinal approaches provide visual function to blind patients.
By Jennifer Kreatsoulas, PHD, Senior Associate Editor
BUSINESS OF RETINA
By Allen Chiang, MD; Paul S. Baker, MD; and Eugene A. Milder, MD; With Sunir J. Garg, MD
An overview of vital dyes and their characteristics.
By Mauricio Maia MD, PHD; Michel EID Farah, MD, PHD; Eduardo B. Rodrigues, MD; Andre Maia, MD; Octaviano Magalhaes JR., MD; and Acacio Lima, PHD
Multifocal ERG is useful in detecting early maculopathy.
By Todd Klesert, MD, PHD
By Andrew A. Moshfeghi, MD, MBA; and Thomas Albini, MD
This is still a valuable treatment in properly selected cases.
By Brad E. Kligman, BS; Carol L. Shields, MD; and Jerry A. Shields, MD
Recent data and status of some ongoing DRCR.net protocols.
By Sharon D. Solomon, MD; and Neil M. Bressler, MD
A review of agents in clinical trials.
By Avner Ingerman, MD, MSC; and Daniel Dewey-Mattia
By Ivan J. Suner, MD
These “hot” eyes can be challenging even for experienced surgeons.
By Tom H. Williamson, MD, MBCHB, FRCS, FRCOPHTH, MD
Excellent outcomes can be achieved in these patients with appropriate attention to details.
By Uday Devgan, MD, FACS, FRCS(GLASG)
By Nancy M. Holekamp, MD and Michael S. Ip, MD
This specialized discipline may play an important role in improving patient outcomes.
By Stephen G. Schwartz, MD, MBA; and M. Elizabeth Fini, PHD
Management of advanced disease may include surgery.
By Manish Nagpal, MS, DO, FRCS(UK); and Pravin Jain, FRF, DNB
By Robert L. Avery, MD
Dr. Aylward is a Consultant Vitreoretinal Surgeon and former Medical Director at Moorfields Eye Hospital in London. He is also President of the European Society of Retina Specialists (Euretina).